Cwm, LLC Immunity Bio, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Cwm, LLC holds 26 shares of IBRX stock, worth $82. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 13 100.0%

Holding current value

$82

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$3.32 - $6.7 $43 - $87	13 Added 100.0%	26 $0
Q2 2024 Jul 09, 2024	BUY	$4.82 - $9.15 $62 - $118	13 New	13 $0
Q1 2022 Apr 21, 2022	SELL	$5.05 - $7.53 $505 - $753	-100 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$7.04 - $17.61 $704 - $1,761	100 New	100 $1,000
Q4 2020 Jan 27, 2021	SELL	$7.04 - $17.61 $704 - $1,761	-100 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$6.37 - $15.36 $637 - $1,536	100 New	100 $1,000
Q3 2020 Oct 19, 2020	SELL	$6.37 - $15.36 $637 - $1,536	-100 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$2.6 - $12.28 $260 - $1,228	100 New	100 $1,000
Q2 2020 Jul 22, 2020	SELL	$2.6 - $12.28 $260 - $1,228	-100 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$2.73 - $7.38 $273 - $738	100 New	100 $1,000
Q1 2020 Apr 28, 2020	SELL	$2.73 - $7.38 $273 - $738	-100 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$1.05 - $3.84 $105 - $384	100 New	100 $1,000
Q4 2019 Jan 27, 2020	SELL	$1.05 - $3.84 $105 - $384	-100 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$1.03 - $1.39 $103 - $139	100 New	100 $1,000
Q3 2019 Oct 22, 2019	SELL	$1.03 - $1.39 $103 - $139	-100 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$1.0 - $1.51 $100 - $151	100 New	100 $1,000
Q2 2019 Jul 31, 2019	SELL	$1.0 - $1.51 $100 - $151	-100 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$1.07 - $1.75 $107 - $175	100 New	100 $0

Others Institutions Holding IBRX

# of Institutions

205

Shares Held

70M

Call Options Held

1.64M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.27B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account